Atreca to Highlight ATRC-101 Preclinical Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

NEXT STORY
Forty Seven Inc. to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019
PREV STORY
Apellis Pharmaceuticals Reports Third Quarter 2019 Business Update and Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Digital PCR (d-PCR) Market Analysis and Forecast, 2020-2025: Rising Incidence of Infectious Disease, Such as COVID-19 Driving the Market

author_avatar
NASDAQ Market News

Five Prime Therapeutics Announces FPA144 Will Be Featured During a Special Session at the 2016 AACR Annual Meeting

SOUTH SAN FRANCISCO, Calif., April 11, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...

author_avatar
NASDAQ Market News

MacroGenics Announces Second Interim Overall Survival Data from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer

author_avatar
NASDAQ Market News